- Noteworthy events for the week of Feb. 25 - March 3 for healthcare investors:
- Monday (2/26): Annual Huntington's Disease Therapeutics Conference, Palm Springs, CA (four days). uniQure (NASDAQ:QURE): preclinical data on gene therapy AMT-130.
- Bank of America/Merrill Lynch Animal Health Summit, NYC. Kindred Biosciences (NASDAQ:KIN): one-on-one meetings; Abaxis (NASDAQ:ABAX).
- Tuesday (2/27): Ionis Pharmaceuticals (NASDAQ:IONS): Q4 results (premarket); TESARO (NASDAQ:TSRO): Q4 results (after the close).
- BTIG Healthcare Conference, Snowbird, UT (four days). Summit Therapeutics (NASDAQ:SMMT), Apellis Pharmaceuticals (NASDAQ:APLS).
- Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction Winter Meeting, Austin, TX (five days). GTx (NASDAQ:GTXI): Phase 2 enobosarm data in women with stress urinary incontinence.
- Wednesday (2/28): Valeant Pharmaceuticals (NYSE:VRX): Q4 results (premarket); Mylan N.V. (NASDAQ:MYL): Q4 results (after the close).
- FDA action date: Vertex Pharmaceuticals (NASDAQ:VRTX): tezacaftor/ivacaftor for CF; Sorrento Therapeutics (NASDAQ:SRNE): ZTildo patch for postherpetic neuralgia.
- Thursday (3/1): Sarepta Therapeutics (NASDAQ:SRPT): Q4 results (premarket).
- Friday (3/2): FDA action date: Otonomy (NASDAQ:OTIC): Otipro for acute otitis externa.
- Now read: Premarket analyst action - healthcare
Original article